Login / Signup

Letter: Comparing first-line infliximab and vedolizumab for ulcerative colitis-it depends on how you use the drug.

Danny ConAshish Srinivasan
Published in: Alimentary pharmacology & therapeutics (2023)
Keyphrases
  • ulcerative colitis
  • adverse drug
  • drug induced